We are live on ! Find out more
EIDX

Eidos Therapeutics, Inc. Common Stock
EIDX

Delisted

EIDX was delisted on the 25th of January, 2021.

Back to rankings

0 hedge funds and large institutions have $0 invested in Eidos Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 120 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 121 → 0 (-121)

100% less funds holding in top 10

Funds holding in top 10: 6 → 0 (-6)

100% less capital invested

Capital invested by funds: $1.45B → $0 (-$1.45B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 120

Holders
–
Holders Change
-121
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
120
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$205M
2
ACM
Aisling Capital Management
New York
-$148M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$119M
4
PA
Perceptive Advisors
New York
-$90.4M
5
MF
Magnetar Financial
Illinois
-$78.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
TCM
51
Tekla Capital Management
Massachusetts
– -$2.63M -20,000 Closed
Skandinaviska Enskilda Banken (SEB)
52
Skandinaviska Enskilda Banken (SEB)
Sweden
– -$2.48M -18,856 Closed
Bank of America
53
Bank of America
North Carolina
– -$2.35M -17,877 Closed
Voloridge Investment Management
54
Voloridge Investment Management
Florida
– -$2.33M -17,741 Closed
California State Teachers Retirement System (CalSTRS)
55
California State Teachers Retirement System (CalSTRS)
California
– -$2.18M -16,552 Closed
WCMNY
56
Westchester Capital Management (New York)
New York
– -$2.12M -16,116 Closed
LOAMU
57
Lombard Odier Asset Management (USA)
New York
– -$2.04M -15,500 Closed
State of Wisconsin Investment Board
58
State of Wisconsin Investment Board
Wisconsin
– -$2.03M -15,400 Closed
UBS AM
59
UBS AM
Illinois
– -$1.85M -14,057 Closed
DekaBank Deutsche Girozentrale
60
DekaBank Deutsche Girozentrale
Germany
– -$1.72M -13,800 Closed
RhumbLine Advisers
61
RhumbLine Advisers
Massachusetts
– -$1.79M -13,585 Closed
BPGAM
62
BTG Pactual Global Asset Management
Bermuda
– -$1.74M -13,204 Closed
Barclays
63
Barclays
United Kingdom
– -$1.73M -13,144 Closed
CL
64
CSS LLC
Illinois
– -$1.61M -12,204 Closed
NAM
65
Nexpoint Asset Management
Texas
– -$1.59M -12,060 Closed
Dimensional Fund Advisors
66
Dimensional Fund Advisors
Texas
– -$1.53M -11,646 Closed
EAM
67
Erste Asset Management
Austria
– -$1.31M -10,500 Closed
AC
68
Athanor Capital
New York
– -$1.38M -10,477 Closed
Allianz Asset Management
69
Allianz Asset Management
Germany
– -$1.32M -10,045 Closed
CC
70
Centiva Capital
New York
– -$1.32M -10,000 Closed
New York State Common Retirement Fund
71
New York State Common Retirement Fund
New York
– -$1.32M -10,000 Closed
CS
72
Credit Suisse
Switzerland
– -$1.27M -9,632 Closed
Deutsche Bank
73
Deutsche Bank
Germany
– -$1.2M -9,072 Closed
ProShare Advisors
74
ProShare Advisors
Maryland
– -$1.1M -8,392 Closed
SO
75
STRS Ohio
Ohio
– -$1.04M -7,900 Closed
1 2
3
4 5

EIDX Hedge Fund Activity: Q1 2021 in Review

0 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Eidos Therapeutics, Inc. Common Stock (EIDX) for Q1 2021, worth a combined $0 — down 100% from $1.45B a quarter earlier.

Sellers outnumbered buyers: 120 funds closed out of EIDX and 0 opened new positions — a net loss of 120 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $205M sold.

  • 0 institutional investors held Eidos Therapeutics, Inc. Common Stock (EIDX) as of Q1 2021, down from 121 in Q4 2020.
  • Funds reported $0 of Eidos Therapeutics, Inc. Common Stock stock for Q1 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Eidos Therapeutics, Inc. Common Stock positions in Q1 2021 and 120 closed out, a net change of -120 holders.
  • The largest Eidos Therapeutics, Inc. Common Stock seller in Q1 2021 was BlackRock, an estimated $205M sold.

Based on aggregated 13F filings for Q1 2021.